Skip to main content
TipRanks
Go Ultimate75% OFF

Atricure (ATRC) Revenue by Segment

397 Followers

Revenue by Segment

Atricure reported revenue by segment of $154.45M in Q3 2026, up 0.6% from Q2 2026 and up 15.0% year over year. This is the highest value since 2021.

Shows how sales split across the company’s product lines and services, revealing which devices or consumables drive growth and profit. For Atricure, this highlights dependence on surgical ablation systems versus consumable disposables (and any emerging product lines), signals where adoption or pricing pressure could affect margins, and points to which segments offer the most upside if clinical adoption or reimbursement improves.

$0.00$25.00M$50.00M$75.00M$100.00M$125.00M$150.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Atricure is transitioning from a MIS-dependent company to one driven by pain management, appendage management and open ablation—MIS revenue has steadily eroded while pain and appendage have accelerated, fueled by cryoSPHERE MAX, new clips and EnCompass adoption. That shift explains the stronger cash generation and raised adjusted‑EBITDA outlook, but investors should watch near‑term risks: international reimbursement softness, a manufacturing transition, anticipated IPR&D charges and new competitive entrants in appendage could compress GAAP margins and accentuate expected Q3 seasonality.

ATRC Revenue by Segment

PeriodOpen AblationMinimally Invasive AblationPain ManagementAppendage ManagementTotal
Q3 2026Sep 30, 2026$54.18M$7.29M$30.50M$62.48M$154.45M
Q2 2026Jun 30, 2026$52.13M$8.05M$29.44M$63.99M$153.60M
Q1 2026Mar 31, 2026$48.60M$8.30M$24.35M$60.01M$141.25M
Q4 2025Dec 31, 2025$49.32M$9.85M$24.44M$56.89M$140.50M
Q3 2025Sep 30, 2025$46.44M$9.29M$22.92M$55.62M$134.27M
Q2 2025Jun 30, 2025$46.82M$10.21M$23.20M$55.91M$136.14M
Q1 2025Mar 31, 2025$42.30M$10.49M$19.06M$51.77M$123.62M
Q4 2024Dec 31, 2024$42.00M$13.02M$19.64M$49.62M$124.28M
Q3 2024Sep 30, 2024$39.21M$12.80M$17.90M$46.00M$115.91M
Q2 2024Jun 30, 2024$39.93M$13.59M$16.25M$46.50M$116.27M
Q1 2024Mar 31, 2024$37.20M$14.43M$13.68M$43.54M$108.85M
Q4 2023Dec 31, 2023$35.77M$14.53M$13.75M$42.50M$106.54M
Q3 2023Sep 30, 2023$33.85M$12.47M$13.14M$38.83M$98.29M
Q2 2023Jun 30, 2023$34.72M$12.74M$13.03M$40.42M$100.92M
Q1 2023Mar 31, 2023$32.43M$11.50M$11.30M$38.27M$93.49M
Q4 2022Dec 31, 2022$30.93M$11.44M$11.42M$34.23M$88.03M
Q3 2022Sep 30, 2022$28.25M$11.52M$10.63M$32.84M$83.25M
Q2 2022Jun 30, 2022$28.28M$11.43M$10.32M$34.50M$84.53M
Q1 2022Mar 31, 2022$25.47M$10.15M$8.15M$30.81M$74.58M
Q4 2021Dec 31, 2021$24.11M$13.01M$6.97M$29.13M$73.22M
Q3 2021Sep 30, 2021$24.58M$11.84M$6.26M$27.77M$70.46M
Q2 2021Jun 30, 2021$25.03M$11.28M$5.72M$29.35M$71.38M
Q1 2021Mar 31, 2021$21.87M$9.66M$3.90M$23.84M$59.27M

Related KPIs